
Read More
Cipla Announces Temporary Supply Pause for Lanreotide Following USFDA Audit...
This has been notified of a temporary suspension in the production of Lanreotide Injection....

This has been notified of a temporary suspension in the production of Lanreotide Injection....

This marks a historic milestone as the first and only treatment approved in the United States for Me...

The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-...

The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years...

The biosimilars division alongside niche product development represents Aurobindo Pharma's main focu...

The company's wholly-owned subsidiary, Nureca Technologies Pvt Ltd, specializes in manufacturing med...

The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-...

The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site op...

With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product port...

The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger ...